Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C.
Although combination antiretroviral therapies seem to be effective at controlling HIV-1 infections regardless of the viral subtype, there is increasing evidence for subtype-specific drug resistance mutations. The order and rates at which resistance mutations accumulate in different subtypes also rem...
Guardado en:
Autores principales: | Susana Posada-Céspedes, Gert Van Zyl, Hesam Montazeri, Jack Kuipers, Soo-Yon Rhee, Roger Kouyos, Huldrych F Günthard, Niko Beerenwinkel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/234cad3e39d142a49b86b6057a9e52e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single-cell mutation identification via phylogenetic inference
por: Jochen Singer, et al.
Publicado: (2018) -
Mutational interactions define novel cancer subgroups
por: Jack Kuipers, et al.
Publicado: (2018) -
Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data
por: Salem Malikic, et al.
Publicado: (2019) -
Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children
por: Beatriz Larru Martinez, et al.
Publicado: (2010) -
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
por: Qomara WF, et al.
Publicado: (2021)